{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T13:13:59Z","timestamp":1791465239343,"version":"4.3.4"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"27","license":[{"start":{"date-parts":[[2011,11,7]],"date-time":"2011-11-07T00:00:00Z","timestamp":1320624000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2011,11,7]],"date-time":"2011-11-07T00:00:00Z","timestamp":1320624000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oncogene"],"published-print":{"date-parts":[[2012,7,5]]},"DOI":"10.1038\/onc.2011.483","type":"journal-article","created":{"date-parts":[[2011,11,7]],"date-time":"2011-11-07T11:46:49Z","timestamp":1320666409000},"page":"3223-3234","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":142,"title":["Twist contributes to hormone resistance in breast cancer by downregulating estrogen receptor-\u03b1"],"prefix":"10.1038","volume":"31","author":[{"given":"F","family":"Vesuna","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Lisok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B","family":"Kimble","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Domek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y","family":"Kato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"van der Groep","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Artemov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Kowalski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"Carraway","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"van Diest","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V","family":"Raman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,11,7]]},"reference":[{"key":"BFonc2011483_CR1","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1677\/joe.0.1800497","volume":"180","author":"SV Angeloni","year":"2004","unstructured":"Angeloni SV, Martin MB, Garcia-Morales P, Castro-Galache MD, Ferragut JA, Saceda M . (2004). Regulation of estrogen receptor-alpha expression by the tumor suppressor gene p53 in MCF-7 cells. J Endocrinol 180: 497\u2013504.","journal-title":"J Endocrinol"},{"key":"BFonc2011483_CR2","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1038\/sj.neo.7900129","volume":"3","author":"ZM Bhujwalla","year":"2001","unstructured":"Bhujwalla ZM, Artemov D, Natarajan K, Ackerstaff E, Solaiyappan M . (2001). Vascular differences detected by MRI for metastatic versus nonmetastatic breast and prostate cancer xenografts. Neoplasia 3: 143\u2013153.","journal-title":"Neoplasia"},{"key":"BFonc2011483_CR3","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/S1534-5807(04)00058-9","volume":"6","author":"P Bialek","year":"2004","unstructured":"Bialek P, Kern B, Yang X, Schrock M, Sosic D, Hong N et al. (2004). A twist code determines the onset of osteoblast differentiation. Dev Cell 6: 423\u2013435.","journal-title":"Dev Cell"},{"key":"BFonc2011483_CR4","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1016\/S0165-6147(02)02109-0","volume":"23","author":"A Bikfalvi","year":"2002","unstructured":"Bikfalvi A, Bicknell R . (2002). Recent advances in angiogenesis, anti-angiogenesis and vascular targeting. Trends Pharmacol Sci 23: 576\u2013582.","journal-title":"Trends Pharmacol Sci"},{"key":"BFonc2011483_CR5","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1038\/5047","volume":"21","author":"EE Cameron","year":"1999","unstructured":"Cameron EE, Bachman KE, Myohanen S, Herman JG, Baylin SB . (1999). Synergy of demethylation and histone deacetylase inhibition in the re-expression of genes silenced in cancer. Nat Genet 21: 103\u2013107.","journal-title":"Nat Genet"},{"key":"BFonc2011483_CR6","doi-asserted-by":"publisher","first-page":"9817","DOI":"10.1074\/jbc.M010840200","volume":"276","author":"RA Campbell","year":"2001","unstructured":"Campbell RA, Bhat-Nakshatri P, Patel NM, Constantinidou D, Ali S, Nakshatri H . (2001). Phosphatidylinositol 3-kinase\/AKT-mediated activation of estrogen receptor alpha: a new model for anti-estrogen resistance. J Biol Chem 276: 9817\u20139824.","journal-title":"J Biol Chem"},{"key":"BFonc2011483_CR7","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1136\/ijgc-00009577-200605000-00008","volume":"16","author":"EY Cho","year":"2006","unstructured":"Cho EY, Choi YL, Chae SW, Sohn JH, Ahn GH . (2006). Relationship between p53-associated proteins and estrogen receptor status in ovarian serous neoplasms. Int J Gynecol Cancer 16: 1000\u20131006.","journal-title":"Int J Gynecol Cancer"},{"key":"BFonc2011483_CR8","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1128\/MCB.15.4.2191","volume":"15","author":"EC deConinck","year":"1995","unstructured":"deConinck EC, McPherson LA, Weigel RJ . (1995). Transcriptional regulation of estrogen receptor in breast carcinomas. Mol Cell Biol 15: 2191\u20132196.","journal-title":"Mol Cell Biol"},{"key":"BFonc2011483_CR9","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/S0960-0760(02)00151-6","volume":"82","author":"LA deGraffenried","year":"2002","unstructured":"deGraffenried LA, Hilsenbeck SG, Fuqua SA . (2002). Sp1 is essential for estrogen receptor alpha gene transcription. J Steroid Biochem Mol Biol 82: 7\u201318.","journal-title":"J Steroid Biochem Mol Biol"},{"key":"BFonc2011483_CR10","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1093\/hmg\/9.5.813","volume":"9","author":"V El Ghouzzi","year":"2000","unstructured":"El Ghouzzi V, Legeai-Mallet L, Aresta S, Benoist C, Munnich A, de Gunzburg J et al. (2000). Saethre-Chotzen mutations cause TWIST protein degradation or impaired nuclear location. Hum Mol Genet 9: 813\u2013819.","journal-title":"Hum Mol Genet"},{"key":"BFonc2011483_CR11","first-page":"488","volume":"10","author":"JS Foster","year":"1996","unstructured":"Foster JS, Wimalasena J . (1996). Estrogen regulates activity of cyclin-dependent kinases and retinoblastoma protein phosphorylation in breast cancer cells. Mol Endocrinol 10: 488\u2013498.","journal-title":"Mol Endocrinol"},{"key":"BFonc2011483_CR12","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1002\/cyto.990010114","volume":"1","author":"MH Fox","year":"1980","unstructured":"Fox MH . (1980). A model for the computer analysis of synchronous DNA distributions obtained by flow cytometry. Cytometry 1: 71\u201377.","journal-title":"Cytometry"},{"key":"BFonc2011483_CR13","first-page":"4026","volume":"60","author":"SA Fuqua","year":"2000","unstructured":"Fuqua SA, Wiltschke C, Zhang QX, Borg A, Castles CG, Friedrichs WE et al. (2000). A hypersensitive estrogen receptor-alpha mutation in premalignant breast lesions. Cancer Res 60: 4026\u20134029.","journal-title":"Cancer Res"},{"key":"BFonc2011483_CR14","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.1200\/JCO.1999.17.5.1474","volume":"17","author":"JM Harvey","year":"1999","unstructured":"Harvey JM, Clark GM, Osborne CK, Allred DC . (1999). Estrogen receptor status by immunohistochemistry is superior to the ligand-binding assay for predicting response to adjuvant endocrine therapy in breast cancer. J Clin Oncol 17: 1474\u20131481.","journal-title":"J Clin Oncol"},{"key":"BFonc2011483_CR15","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1006\/excr.1997.3541","volume":"232","author":"M Hebrok","year":"1997","unstructured":"Hebrok M, Fuchtbauer A, Fuchtbauer EM . (1997). Repression of muscle-specific gene activation by the murine Twist protein. Exp Cell Res 232: 295\u2013303.","journal-title":"Exp Cell Res"},{"key":"BFonc2011483_CR16","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1210\/er.2003-0010","volume":"25","author":"MH Herynk","year":"2004","unstructured":"Herynk MH, Fuqua SA . (2004). Estrogen receptor mutations in human disease. Endocr Rev 25: 869\u2013898.","journal-title":"Endocr Rev"},{"key":"BFonc2011483_CR17","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1007\/978-0-387-74039-3_10","volume":"608","author":"MH Herynk","year":"2007","unstructured":"Herynk MH, Fuqua SA . (2007). Estrogen receptors in resistance to hormone therapy. Adv Exp Med Biol 608: 130\u2013143.","journal-title":"Adv Exp Med Biol"},{"key":"BFonc2011483_CR18","doi-asserted-by":"publisher","first-page":"10801","DOI":"10.1158\/0008-5472.CAN-05-0712","volume":"65","author":"Y Mironchik","year":"2005","unstructured":"Mironchik Y, Winnard Jr PT, Vesuna F, Kato Y, Wildes F, Pathak AP et al. (2005). Twist overexpression induces in vivo angiogenesis and correlates with chromosomal instability in breast cancer. Cancer Res 65: 10801\u201310809.","journal-title":"Cancer Res"},{"key":"BFonc2011483_CR19","doi-asserted-by":"publisher","first-page":"2773","DOI":"10.1210\/endo-119-6-2773","volume":"119","author":"M Morisset","year":"1986","unstructured":"Morisset M, Capony F, Rochefort H . (1986). Processing and estrogen regulation of the 52-kilodalton protein inside MCF7 breast cancer cells. Endocrinology 119: 2773\u20132782.","journal-title":"Endocrinology"},{"key":"BFonc2011483_CR20","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/S0960-0760(97)00084-8","volume":"62","author":"LC Murphy","year":"1997","unstructured":"Murphy LC, Dotzlaw H, Leygue E, Douglas D, Coutts A, Watson PH . (1997). Estrogen receptor variants and mutations. J Steroid Biochem Mol Biol 62: 363\u2013372.","journal-title":"J Steroid Biochem Mol Biol"},{"key":"BFonc2011483_CR21","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1016\/0092-8674(89)90682-X","volume":"56","author":"C Murre","year":"1989","unstructured":"Murre C, McCaw PS, Baltimore D . (1989). A new DNA binding and dimerization motif in immunoglobulin enhancer binding, daughterless, MyoD, and myc proteins. Cell 56: 777\u2013783.","journal-title":"Cell"},{"key":"BFonc2011483_CR22","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1038\/sj.bjc.6600028","volume":"86","author":"AM O'Doherty","year":"2002","unstructured":"O'Doherty AM, Church SW, Russell SE, Nelson J, Hickey I . (2002). Methylation status of oestrogen receptor-alpha gene promoter sequences in human ovarian epithelial cell lines. Br J Cancer 86: 282\u2013284.","journal-title":"Br J Cancer"},{"key":"BFonc2011483_CR23","first-page":"1344","volume":"15","author":"AS Oh","year":"2001","unstructured":"Oh AS, Lorant LA, Holloway JN, Miller DL, Kern FG, El-Ashry D . (2001). Hyperactivation of MAPK induces loss of ERalpha expression in breast cancer cells. Mol Endocrinol 15: 1344\u20131359.","journal-title":"Mol Endocrinol"},{"key":"BFonc2011483_CR24","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1146\/annurev.med.56.062804.103324","volume":"56","author":"C Osborne","year":"2005","unstructured":"Osborne C, Tripathy D . (2005). Aromatase inhibitors: rationale and use in breast cancer. Annu Rev Med 56: 103\u2013116.","journal-title":"Annu Rev Med"},{"key":"BFonc2011483_CR25","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1023\/A:1006132427948","volume":"51","author":"CK Osborne","year":"1998","unstructured":"Osborne CK . (1998). Steroid hormone receptors in breast cancer management. Breast Cancer Res Treat 51: 227\u2013238.","journal-title":"Breast Cancer Res Treat"},{"key":"BFonc2011483_CR26","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.jsbmb.2005.04.021","volume":"95","author":"CK Osborne","year":"2005","unstructured":"Osborne CK, Schiff R . (2005). Aromatase inhibitors: future directions. J Steroid Biochem Mol Biol 95: 183\u2013187.","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"Suppl 1","key":"BFonc2011483_CR27","doi-asserted-by":"publisher","first-page":"S2","DOI":"10.1038\/sj.bjc.6601629","volume":"90","author":"CK Osborne","year":"2004","unstructured":"Osborne CK, Wakeling A, Nicholson RI . (2004). Fulvestrant: an oestrogen receptor antagonist with a novel mechanism of action. Br J Cancer 90(Suppl 1): S2\u2013S6.","journal-title":"Br J Cancer"},{"key":"BFonc2011483_CR28","doi-asserted-by":"publisher","first-page":"3172","DOI":"10.1200\/JCO.2000.18.17.3172","volume":"18","author":"CK Osborne","year":"2000","unstructured":"Osborne CK, Zhao H, Fuqua SA . (2000). Selective estrogen receptor modulators: structure, function, and clinical use. J Clin Oncol 18: 3172\u20133186.","journal-title":"J Clin Oncol"},{"key":"BFonc2011483_CR29","first-page":"2552","volume":"54","author":"YL Ottaviano","year":"1994","unstructured":"Ottaviano YL, Issa JP, Parl FF, Smith HS, Baylin SB, Davidson NE . (1994). Methylation of the estrogen receptor gene CpG island marks loss of estrogen receptor expression in human breast cancer cells. Cancer Res 54: 2552\u20132555.","journal-title":"Cancer Res"},{"key":"BFonc2011483_CR30","first-page":"2575","volume":"18","author":"MJ Pilat","year":"1998","unstructured":"Pilat MJ, Schwab ED, Yao KL, Pienta KJ . (1998). Examination of the DNA methylation properties in nontumorigenic and tumorigenic breast epithelial cell lines. Anticancer Res 18: 2575\u20132582.","journal-title":"Anticancer Res"},{"key":"BFonc2011483_CR31","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1093\/jnci\/87.6.446","volume":"87","author":"N Roodi","year":"1995","unstructured":"Roodi N, Bailey LR, Kao WY, Verrier CS, Yee CJ, Dupont WD et al. (1995). Estrogen receptor gene analysis in estrogen receptor-positive and receptor-negative primary breast cancer. J Natl Cancer Inst 87: 446\u2013451.","journal-title":"J Natl Cancer Inst"},{"key":"BFonc2011483_CR32","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1016\/S0168-9525(97)01296-1","volume":"13","author":"CS Rose","year":"1997","unstructured":"Rose CS, Malcolm S . (1997). A TWIST in development. Trends Genet 13: 384\u2013387.","journal-title":"Trends Genet"},{"issue":"Suppl 1","key":"BFonc2011483_CR33","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1007\/s00280-005-0108-2","volume":"56","author":"R Schiff","year":"2005","unstructured":"Schiff R, Massarweh SA, Shou J, Bharwani L, Arpino G, Rimawi M et al. (2005). Advanced concepts in estrogen receptor biology and breast cancer endocrine resistance: implicated role of growth factor signaling and estrogen receptor coregulators. Cancer Chemother Pharmacol 56(Suppl 1): 10\u201320.","journal-title":"Cancer Chemother Pharmacol"},{"key":"BFonc2011483_CR34","first-page":"609","volume":"22","author":"K Sengupta","year":"2003","unstructured":"Sengupta K, Banerjee S, Saxena N, Banerjee SK . (2003). Estradiol-induced vascular endothelial growth factor-A expression in breast tumor cells is biphasic and regulated by estrogen receptor-alpha dependent pathway. Int J Oncol 22: 609\u2013614.","journal-title":"Int J Oncol"},{"key":"BFonc2011483_CR35","doi-asserted-by":"publisher","first-page":"2294","DOI":"10.1074\/jbc.M411018200","volume":"280","author":"IA Stasinopoulos","year":"2005","unstructured":"Stasinopoulos IA, Mironchik Y, Raman A, Wildes F, Winnard Jr P, Raman V . (2005). HOXA5-twist interaction alters p53 homeostasis in breast cancer cells. J Biol Chem 280: 2294\u20132299.","journal-title":"J Biol Chem"},{"key":"BFonc2011483_CR36","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1593\/neo.91084","volume":"11","author":"F Vesuna","year":"2009","unstructured":"Vesuna F, Lisok A, Kimble B, Raman V . (2009). Twist modulates breast cancer stem cells by transcriptional regulation of CD24 expression. Neoplasia 11: 1318\u20131328.","journal-title":"Neoplasia"},{"key":"BFonc2011483_CR37","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.bbrc.2007.11.151","volume":"367","author":"F Vesuna","year":"2008","unstructured":"Vesuna F, van Diest P, Chen JH, Raman V . (2008). Twist is a transcriptional repressor of E-cadherin gene expression in breast cancer. Biochem Biophys Res Commun 367: 235\u2013241.","journal-title":"Biochem Biophys Res Commun"},{"key":"BFonc2011483_CR38","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.cancergencyto.2006.01.014","volume":"167","author":"F Vesuna","year":"2006","unstructured":"Vesuna F, Winnard Jr P, Glackin C, Raman V . (2006). Twist overexpression promotes chromosomal instability in the breast cancer cell line MCF-7. Cancer Genet Cytogenet 167: 189\u2013191.","journal-title":"Cancer Genet Cytogenet"},{"key":"BFonc2011483_CR39","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.ab.2005.04.047","volume":"342","author":"F Vesuna","year":"2005","unstructured":"Vesuna F, Winnard Jr P, Raman V . (2005). Enhanced green fluorescent protein as an alternative control reporter to Renilla luciferase. Anal Biochem 342: 345\u2013347.","journal-title":"Anal Biochem"},{"key":"BFonc2011483_CR40","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1023\/A:1011308707512","volume":"6","author":"L Yan","year":"2001","unstructured":"Yan L, Yang X, Davidson NE . (2001). Role of DNA methylation and histone acetylation in steroid receptor expression in breast cancer. J Mammary Gland Biol Neoplasia 6: 183\u2013192.","journal-title":"J Mammary Gland Biol Neoplasia"}],"container-title":["Oncogene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/onc2011483.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/onc2011483","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/onc2011483.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,21]],"date-time":"2022-03-21T18:25:45Z","timestamp":1647887145000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/onc2011483"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,11,7]]},"references-count":40,"journal-issue":{"issue":"27","published-print":{"date-parts":[[2012,7,5]]}},"alternative-id":["BFonc2011483"],"URL":"https:\/\/doi.org\/10.1038\/onc.2011.483","relation":{},"ISSN":["0950-9232","1476-5594"],"issn-type":[{"value":"0950-9232","type":"print"},{"value":"1476-5594","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,11,7]]},"assertion":[{"value":"5 April 2011","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 September 2011","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 September 2011","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 November 2011","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}